University Of Arkansas
Clinical trials sponsored by University Of Arkansas, explained in plain language.
-
Could greek yogurt help Post-Menopausal women build muscle and control blood sugar?
Disease control Not yet recruitingThis study investigates whether eating two servings of Greek yogurt daily—either whole milk or skimmed—can improve muscle protein synthesis, blood sugar control, and thinking skills in post-menopausal women who are overweight or have obesity. Participants will follow a standardiz…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could a measles vaccine fight pancreatic cancer?
Disease control Not yet recruitingThis early-phase trial is testing whether injecting the MMR vaccine directly into pancreatic tumors is safe and can help shrink them. The study will include 20 adults with borderline resectable or unresectable pancreatic cancer who have already completed standard chemotherapy and…
Phase: PHASE1, PHASE2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug cocktail aims to outsmart aggressive myeloma
Disease control Not yet recruitingThis phase 2 trial tests whether giving two bispecific antibodies (teclistamab and talquetamab) in sequence, along with other drugs, can improve survival in 50 people with high-risk multiple myeloma. Some participants may also receive a stem cell transplant if cancer cells remain…
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a 5-Session writing therapy ease PTSD in new moms?
Symptom relief Not yet recruitingThis study explores whether a short, evidence-based therapy called Written Exposure Therapy (WET) can help pregnant and postpartum women who have PTSD and a history of substance misuse. Participants receive five weekly telehealth sessions where they write about a traumatic experi…
Phase: NA • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a tiny dose of naltrexone beat cancer fatigue?
Symptom relief Not yet recruitingThis phase 2 trial tests whether a low dose of naltrexone (LDN) can reduce fatigue in men with prostate cancer who are on hormone therapy (ADT). The study will enroll 60 participants and measure fatigue, quality of life, and safety. It is not yet recruiting.
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Teaching the brain to tame pain: a virtual approach to enhance spinal cord stimulation
Symptom relief Not yet recruitingThis pilot trial tests whether adding virtual pain neuroscience education to standard spinal cord stimulation can help chronic pain patients better manage their condition. The education teaches how the brain processes pain, aiming to reduce fear, anxiety, and catastrophizing. Par…
Phase: NA • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Phone calls after birth: a simple way to save lives?
Knowledge-focused Not yet recruitingThis study tests whether three telehealth visits with a community health worker after childbirth can help new mothers complete their postpartum checkup and spot complications sooner. Researchers will compare 500 women who get these calls plus standard care against those who only …
Phase: NA • Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can online training boost Doctors' skills to help smokers quit and catch lung cancer early?
Knowledge-focused Not yet recruitingThis study tests whether an online training course for healthcare providers can improve their knowledge, attitudes, and intentions to help patients quit smoking and get screened for lung cancer. About 300 providers who are members of the National Medical Association and serve pat…
Phase: NA • Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC